173 related articles for article (PubMed ID: 7293030)
1. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer].
Hájek J; Hanselová M; Vrubel F
Vnitr Lek; 1981 Sep; 27(9):852-60. PubMed ID: 7293030
[No Abstract] [Full Text] [Related]
2. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
Kalland T; Haukaas S
Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients.
Lukkarinen O; Hammond GL; Kontturi M; Vihko R
Invest Urol; 1980 Jan; 17(4):328-31. PubMed ID: 6444293
[TBL] [Abstract][Full Text] [Related]
4. Effects of estrogen treatment on human testicular unconjugated steroid and steroid sulfate production in vivo.
Leinonen P; Ruokonen A; Kontturi M; Vihko R
J Clin Endocrinol Metab; 1981 Sep; 53(3):569-73. PubMed ID: 7263840
[No Abstract] [Full Text] [Related]
5. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
Stahl F; Schnorr D; Rohde W; Dörner G
Z Urol Nephrol; 1987 Mar; 80(3):135-8. PubMed ID: 3604472
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment hormone levels in prostatic cancer.
Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
[TBL] [Abstract][Full Text] [Related]
7. Urinary oxalate excretion during anti-androgenic therapy.
Tiselius HG; Varenhorst E; Carlström K; Larsson L
Invest Urol; 1980 Sep; 18(2):110-1. PubMed ID: 6447675
[TBL] [Abstract][Full Text] [Related]
8. [Effects of gonadal hormones on the lipid spectrum of plasma].
Para Cabello J; Jover Sanz E; Velasco Alonso R
Rev Clin Esp; 1974 Sep; 134(5):449-60. PubMed ID: 4438740
[No Abstract] [Full Text] [Related]
9. [Plasma testosterone and sex hormone transport globulin in patients with prostatic carcinoma under treatment].
Daponte DP; Pidcock M; Robinson MR; Smith PH
Actas Urol Esp; 1982; 6(1):17-20. PubMed ID: 7200715
[No Abstract] [Full Text] [Related]
10. Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen.
Noland JL; Amin M
Invest Urol; 1980 May; 17(6):506-9. PubMed ID: 7372439
[TBL] [Abstract][Full Text] [Related]
11. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract Suppl; 1985 Mar; 37():8-12, 20-4. PubMed ID: 3931665
[No Abstract] [Full Text] [Related]
12. Endocrine factors in the treatment of prostatic cancer.
Pierrepoint CG; Turkes AO; Walker KJ; Harper ME; Wilson DW; Peeling WB; Griffiths K
Prog Clin Biol Res; 1985; 185A():51-72. PubMed ID: 3162177
[No Abstract] [Full Text] [Related]
13. Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate.
Kemp HA; Read GF; Riad-Fahmy D; Pike AW; Gaskell SJ; Queen K; Harper ME; Griffiths K
Cancer Res; 1981 Nov; 41(11 Pt 1):4693-7. PubMed ID: 7306985
[TBL] [Abstract][Full Text] [Related]
14. Prostatic carcinoma cured with hormonal treatment. A report of two cases.
Johansson S; Ljunggren E
Scand J Urol Nephrol; 1981; 15(3):321-2. PubMed ID: 7323757
[No Abstract] [Full Text] [Related]
15. Hormonal pattern in prostatic cancer. II. Correlation with primary response to endocrine treatment.
Adlercreutz H; Rannikko S; Kairento AL; Karonen SL
Acta Endocrinol (Copenh); 1981 Dec; 98(4):634-40. PubMed ID: 7304086
[TBL] [Abstract][Full Text] [Related]
16. Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer.
Bong GW; Clarke HS; Hancock WC; Keane TE
Urology; 2008 Jun; 71(6):1177-80. PubMed ID: 18279929
[TBL] [Abstract][Full Text] [Related]
17. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
Kobayashi T; Nishizawa K; Mitsumori K
Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
[TBL] [Abstract][Full Text] [Related]
18. Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.
Lindstedt E
Scand J Urol Nephrol Suppl; 1980; 55():95-7. PubMed ID: 6938044
[TBL] [Abstract][Full Text] [Related]
19. Effect of hormones on the growth of virus-transformed hamster prostatic tissue.
Fraley EE; Paulson DF
Surg Forum; 1968; 19():544-5. PubMed ID: 4304976
[No Abstract] [Full Text] [Related]
20. [Primary orchiectomy in prostatic cancer].
Johansen S; Sander S
Tidsskr Nor Laegeforen; 1982 Sep; 102(25):1267-9. PubMed ID: 6187086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
